Evolutionary.org Evolutionary Spanish Evolutionary Russian
Join Evolutionary Forums

UFC Fighter Tests Positive For Steroids

Sign up to Get FREE Steroids, SARMS, Peptides eBooks

Hector Lombard, the Cuban-Australian professional mixed martial artist and former Olympic judoka who competes as a Welterweight in the Ultimate Fighting Championship, has tested positive for anabolic steroids following his UFC 182 victory over Josh Burkman on January 3 in Las Vegas.

Hector Lombard

The drug test result was confirmed by Nevada Athletic Commission executive director Bob Bennett. As a result of the test, the UFC 186 co-main event bout between Rory MacDonald and Hector Lombard has been pulled from the fight card.

The result report was provided to the Nevada Athletic Commission on January 13. The sample was collected on January 3, the night of the fight. The positive test result of Hector Lombard comes during a period of major upheaval in regard to use of banned drugs in MMA. UFC light heavyweight champion Jon Jones recently tested positive for cocaine metabolites during an out-of-competition drug test leading up to his UFC 182 successful title defense against Daniel Cormier, former middleweight kingpin Anderson Silva tested positive for two anabolic steroids on a January 9 out-of-competition test leading up to his UFC 183 main event bout against Nick Diaz, and Diaz tested positive for marijuana metabolites.

The UFC fighter tested positive for was Desoxymethyltestosterone, commonly known as Madol. Madol is a strength and muscle gaining steroid that is 60 percent more anabolic than Testosterone but only 60 percent as androgenic as Testosterone.

Lombard is likely to face a fine and suspension and the result of his UFC 182 bout will likely be changed from a victory over Burkman to a no contest result. All three are expected to fined and suspended while Silva and Lombard could have their wins overturned. Women’s bantamweight Ashlee Evans-Smith also faces disciplinary action at the February 17 NSAC meeting for failing her UFC 181 post-fight drug test for diuretics.

UFC Chairman and CEO Lorenzo Fertitta and President Dana White, following a string of positive drug tests, will hold a press conference on February 18 in Las Vegas.

In January, the UFC abandoned a plan to implement out-of-competition drug tests to its entire roster after Cung Le fought a positive test for Human growth hormone (HGH) stemming from his UFC Fight Night 48 loss to Michael Bisping and had his suspension rescinded.

Le made his pro MMA debut in March 2006. The former professional kickboxer won his first six bouts and captured the Strikeforce 185-pound title in a TKO victory against Frank Shamrock in March 2008. Lee, former Strikeforce middleweight champion and UFC veteran, announced his retirement from mixed martial arts in January this year. Le (9-3) formally declared he would not compete in MMA again and said after several months of thought and discussion with my wife and family, we realize our future includes many things and added but active competition in mixed martial arts is no longer one of them and therefore he is officially announcing his retirement from active competition. On his retirement, UFC Chairman and CEO Lorenzo Fertitta said Cung Le was a great ambassador of the sport for us in Asia and one of the most exciting middleweights to step foot in the Octagon and we wish him well in his retirement and future endeavors.

Sign up to Get FREE Steroids, SARMS, Peptides eBooks

Have your say!

0 0
Avatar photo
Written by
Albert Wolfgang is a professional medical writer with over 20 years of experience. He hold multiple personal training certifications, including the coveted NASM and AFAA certificates. He graduated with honors with a B.S. and M.S. in biochemistry with a minor in physical studies. Albert and his team have trained over 100 IFBB professional bodybuilders, including Hollywood stars and many up and coming fitness stars.

Leave a Reply

Lost Password

Please enter your username or email address. You will receive a link to create a new password via email.